RxDoctor Payments Data
★ My doctorsLook up a doctor →

Darshan Patel

Schertz, TXNPI 1427513571

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations.

$2,071in general payments, 2019–2025

Across 93 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$259
  • Takeda Pharmaceuticals U.S.A., Inc.$250
  • Regeneron Healthcare Solutions, Inc.$242
  • CSL Behring$222
  • Optinose US, Inc.$148
  • Amgen$147
  • plus $803 from 15 others

What the payments were for

  • Food & beverage$2,071100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK13$259
Takeda Pharmaceuticals U.S.A., Inc.10$250
Regeneron Healthcare Solutions, Inc.9$242
CSL Behring11$222
Optinose US, Inc.7$148
Amgen7$147
Kaleo, Inc.5$116
Sanofi4$95
AstraZeneca4$80
Grifols USA, LLC4$77
Genentech USA, Inc.3$73
Alk-abello, Inc2$50
Incyte Corporation2$48
Boehringer Ingelheim2$47
Biocryst US Sales Co., LLC2$42
Pfizer2$40
Pharming Healthcare, Inc.2$37
Organon1$30
Novartis1$30
Paratek Pharmaceuticals, Inc.1$21
Aimmune Therapeutics, Inc.1$16

Where these figures come from

Is this you, or does something look wrong? →